The objectives of the study were to investigate the distribution of cphA-related genes (cphA) encoding a CphA metallo-b-lactamase (MBL) among 51 consecutive Aeromonas blood isolates and to compare different phenotypic methods for detecting CphA. The presence of cphA was detected by PCR. Four phenotypic methods, the imipenem-EDTA combined disc test, imipenem-EDTA MBL Etest, agar dilution test and modified Hodge test (MHT), were used to detect imipenem susceptibility and MBL production. The results showed that 35 (69 %) blood isolates had cphA. All (100 %) of 16 Aeromonas aquariorum isolates and 12 Aeromonas veronii isolates, and 4 (80 %) of 5 Aeromonas hydrophila isolates, carried cphA, but none of 15 Aeromonas caviae isolates did. With the standard inocula, irrespective of the presence or absence of cphA, all but one (50, 98 %) isolates were susceptible to imipenem tested by disc diffusion, Etest and agar dilution (10 4 c.f.u. spot inocula), and did not exhibit MBL production by the imipenem-EDTA combined disc test and MBL Etest. By the agar dilution test using large inocula (10 7 c.f.u.), 34
INTRODUCTION
Aeromonads, oxidase-producing Gram-negative rods, are aquatic micro-organisms and have been implicated in a variety of human diseases, ranging from mild gastroenteritis (Janda & Abbott, 2010) to fatal septicaemia, peritonitis/abdominal sepsis (Wu et al., 2009 ) and necrotizing fasciitis (Lee et al., 2008) . Three principal classes of chromosomally mediated b-lactamases have been recognized in Aeromonas species, i.e. Ambler class C cephalosporinases, class D penicillinases and class B metallo-b-lactamases (MBLs) (Janda & Abbott, 2010) . Fosse et al. (2003) characterized the strains producing these b-lactamases into five major phenotypes: Aeromonas hydrophila complex/class B, C and D b-lactamases; Aeromonas caviae complex/class C and D b-lactamases; Aeromonas veronii complex/class B and D b-lactamases; Aeromonas schubertii spp./class D b-lactamase; and Aeromonas trota spp./class C b-lactamase.
The most commonly found MBL in Aeromonas species is CphA, which was first named in 1991 (Massidda et al., 1991) . In addition to CphA, other MBLs have been identified in aeromonads, including ImiS (Walsh et al., 1998) , IMP-19 (Neuwirth et al., 2007) and VIM (Libisch et al., 2008) . CphA, a metalloenzyme, is inhibited by metal chelators, such as EDTA (Massidda et al., 1991; Segatore et al., 1993) . Compared with other class B enzymes, CphA MBL has a very specific substrate profile, being active on penem and carbapenem only, and not on penicillin and cephalosporins (Segatore et al., 1993) . The distribution of cphA-related genes is species-related: they are mainly found in isolates of A. hydrophila, A. veronii and Aeromonas jandaei, but not in A. caviae (Balsalobre et al., 2009; Rossolini et al., 1995) . However, CphA MBL production is not easily detected by in vitro susceptibility testing unless using large inocula. Tested by the agar dilution method with a larger inoculum (10 8 c.f.u.), the imipenem MICs for Aeromonas strains with cphA-related genes were ¢4 mg ml 21 , higher than the susceptible breakpoint, in a study by Rossolini et al. (1995) .
Recent developments in the field of Aeromonas taxonomy based on genetic identification have led to a reclassification of aeromonads and to the description of novel species. For example, several clinical isolates from Taiwan were identified as A. aquariorum ), a recently described species found in aquarium water and ornamental fish (Martínez-Murcia et al., 2008) . Furthermore, A. aquariorum was found to be widely distributed in clinical and environmental specimens, and could be misidentified as A. hydrophila (Aravena-Román et al., 2011) . A. aquariorum can be associated with diarrhoea, bacteraemia, skin and soft tissue infections, and other extraintestinal infections, and clinicians should be aware of this novel clinically relevant species ). An understanding of the b-lactamase types intrinsically harboured in this novel species would be a guide for antimicrobial therapy. However, current knowledge about cphA distribution in this novel species is limited.
In this work, we investigated the prevalence of cphA-related genes and evaluated different phenotypic methods for detecting CphA MBL in reference strains and blood isolates of different Aeromonas species, trying to expand the knowledge of the occurrence and distribution of CphA MBL and cphA-related genes in the members of the genus Aeromonas, with special attention to the novel species A. aquariorum.
METHODS
Bacterial isolates and species identification. Consecutive Aeromonas blood isolates at National Cheng Kung University Hospital, a medical centre in southern Taiwan, were collected from June 1999 to June 2001 and stored at 270 uC until use. Only the first isolate of the same species from each patient was studied. During the study period, 51 blood isolates from 47 patients were available. An Aeromonas blood isolate, A2-1000804, which was collected in 2011 from a patient with a febrile episode while receiving the 7th day of ertapenem therapy for biliary tract infection caused by Escherichia coli producing extended-spectrum b-lactamase, was also included. The genus Aeromonas was identified by positive oxidase test, fermentation of D-glucose, motility, the absence of growth in 6.5 % sodium chloride and resistance to the vibriostatic agent O/129 (150 mg), and was confirmed by the GNI Plus system (Vitek Systems; bioMérieux) or API 20E system (bioMérieux). Species identification was based on both the Vitek system or API 20E system and sequence analyses of the partial rpoB gene obtained by PCR with the primers Pasrpob-L (59-GCAGTGAAAGARTTCTTTGGTTC-39) and Rpob-R (59-GTTGC-ATGTTNGNACCCAT-39) (Küpfer et al., 2006) . The sequences of amplified DNA products, around 500 bp, were compared with reference sequences available in GenBank (http://www.ncbi.nlm.nih. gov/BLAST/). Based on the rpoB results, isolates with a dissimilarity value ¡0.9 % for a given type strain were identified to that species (Lamy et al., 2010 (Massidda et al., 1991; Talavera et al., 2006) , with similar conditions for the rpoB gene amplification except for the annealing temperature, which was changed to 53 uC. The procedures for colony hybridization followed the manufacturer's instructions (DIG DNA Labelling kit; Roche), in which the hybridization probes were designed from the amplified DNA products of isolates of A. aquariorum A2-5, A. veronii A2-7 and A. hydrophila A2-11, around 720 bp. The amplified DNA sequences of these three isolates were 94 % identical to those of the A. hydrophila AE036 cphA genes.
All imipenem-non-susceptible isolates were examined for other genes encoding MBLs, including bla IMP and bla VIM genes by previously described PCR primers for IMP and VIM families and conditions (Balsalobre et al., 2009) . Two isolates of Pseudomonas aeruginosa with the bla VIM-3 gene and two isolates of Klebsiella pneumoniae with the bla IMP-8 gene were used as positive control strains.
Imipenem susceptibility and expression of MBL. The discs with imipenem (10 mg) alone or associated with EDTA (10 ml, 0.5 M), the MBL Etest (BD BIODISK, imipenem 4-256 mg ml 21 and imipenem 1-64 mg ml 21 +EDTA) and the agar dilution test (imipenem 0.5-16 mg ml
21
) were used to detect imipenem susceptibility and MBL production. The procedures for the disc diffusion test, Etest and agar dilution test followed the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2009 (CLSI, , 2010 . As recommended by the CLSI, standard inocula of 0.5 McFarland for the disc diffusion test and Etest and spot inocula of 10 4 c.f.u. for the agar dilution test were used. Larger inocula of 1.5 McFarland for the disc diffusion test and Etest and spot inocula of 10 7 c.f.u. for the agar dilution test were also adopted. Interpretation of imipenem susceptibility followed the CLSI recommendations for Aeromonas species (CLSI, 2010) , and results determined with both standard and large inocula adopted the same interpretative criteria for comparison in this study. Isolates that did not fit the criteria of 'susceptible', and belonged to the categories of 'intermediate' and 'resistant', were classified as being 'non-susceptible'. A .7 mm increase in the inhibition zone diameter in the presence of imipenem associated with EDTA in comparison with that of imipenem alone was interpreted as evidence of MBL production (Yong et al., 2002) . By MBL Etest, the expression of MBL was reflected by a reduction of imipenem MIC by at least eightfold, the appearance of a phantom zone or deformation of the imipenem ellipse in the presence of EDTA. P. aeruginosa ATCC 27853 T , negative for MBL, was used as the quality control strain. The modified Hodge test (MHT) followed the CLSI standards of a confirmatory test for carbapenemase production in members of the Enterobacteriaceae (CLSI, 2009), and an ertapenem disc (10 mg) was the carbapenem used.
Clinical data. Medical records of patients with bacteraemia due to Aeromonas species during the study period were reviewed. The clinical outcome of patients treated by carbapenems was analysed.
RESULTS

Species and cphA-related genes distribution
By sequence analyses of the partial rpoB genes, 16, 11 and 8 isolates were identified as A. aquariorum, A. caviae and A. veronii, with a dissimilarity value ¡0.9 % for the rpoB genes of A. aquariorum DSM 18362 T (GenBank accession no. FM210471), A. caviae strain V83 (GenBank accession no. AY851107) and A. veronii strain JF2638 (GenBank accession no. AY851124), respectively. Based on typical phenotypic reactions in the Vitek or API 20E system and rpoB gene sequences with 98.6-98.8 % identity to that of A. caviae strain V83, another four isolates were identified as A. caviae. Likewise, four isolates were identified as A. veronii because their rpoB gene sequences had 98.6-98.8 % identity to that of A. veronii strain JF2638 and they showed typical phenotypic reactions, and five isolates were identified as A. hydrophila because their rpoB sequences had 98.0-98.6 % identity to that of A. hydrophila ATCC 7966 (GenBank accession no. CP000462). However, species identification of three isolates was not possible due to incompatible results of the phenotypic identification and the rpoB sequencing. Overall, 51 blood isolates were identified as A. aquariorum (16, 31 %), A. caviae (15, 29 %), A. veronii (12, 24 %), A. hydrophila (5, 10 %) and Aeromonas species (3, 4 %). Some of the isolates had been described previously (Wu et al., 2007; Figueras et al., 2009 T and 34 blood isolates, around 720 bp, corresponded to that of the A. hydrophila AE036 cphA gene (GenBank accession no. X57102) with an identity of 93-95 %. The PCR product of A2-155 had an extra 219 nt inserted sequence compared to A. hydrophila AE036 cphA genes (Fig. S1 ). The GenBank accession numbers for the sequences of cphA-related genes of A. aquariorum MDC47
T and 10 published A. aquariorum blood isolates (with the exception of A2-155) are JF972618-JF972628.
cphA and imipenem susceptibility
The results of three phenotypic methods for imipenem susceptibility testing of reference strains and 51 blood isolates are shown in Tables 1, 2 and 3, respectively. Using the three methods of disc diffusion, Etest and agar dilution to study imipenem susceptibility among 35 isolates carrying cphA, imipenem non-susceptibility was detected in one (3 %) isolate with the standard inoculum, while it was detected among 12 (34 %), 17 (49 %) and 34 (97 %) isolates, respectively, with a large inoculum. Of note, 34 cphA + isolates were resistant to imipenem (MICs ¢16 mg ml 21 ), as studied by the agar dilution test with a large inoculum, and were negative for bla IMP and bla VIM genes. By either the imipenem-EDTA combined disc test or MBL Etest, only 1 (3 %) of 34 cphA + isolates exhibited an MBL-producing phenotype, while 10 (29 %) and 17 (49 %) isolates, respectively, did so with a large inoculum. None of 16 cphA 2 isolates exhibited imipenem nonsusceptibility or an MBL-producing phenotype with either a standard or large inoculum. Similarly, imipenem non-susceptibility in three cphA + reference strains was only demonstrated by the agar dilution test with a large inoculum.
Unlike most cphA + strains, two cphA + A. aquariorum isolates, A2-107 and A2-1000804, constantly exhibited imipenem non-susceptibility (MIC: 24 and .32 mg ml
21
by Etest with a standard inoculum, respectively) and expressed the MBL-producing phenotype by the imipenem-EDTA combined disc test and MBL Etest with either a standard or large inoculum. In contrast, one cphA + A. aquariorum isolate, A2-155, was always susceptible to imipenem by the three susceptibility tests with either inoculum. (Fig. 1a-e) . The MHT results for one cphA + isolate (A. aquariorum A2-155) (Fig. 1f) and two cphA 2 A. caviae isolates were indeterminate because the indentation between the aeromonad streak and the margin of ertapenem inhibition zone was not obvious. The indeterminate MHT result for A2-155 was correlated with that of the agar dilution test with a large inoculum, in which imipenem non-susceptibility could not be demonstrated either. Overall, the MHT could detect carbapenemase activity in 34 (100 %) imipenem-nonsusceptible blood isolates.
MHT and imipenem susceptibility
Clinical data
Among 47 patients with Aeromonas bacteraemia from June 1999 to June 2001, only one patient had ever received carbapenem therapy. This patient with cphA + A. veronii and Enterobacter cloacae bacteraemia received an aminoglycoside active against both E. cloacae and A. veronii at bacteraemia onset and imipenem 1 week after bacteraemia onset and survived. The clinical condition of the patient with breakthrough bacteraemia due to A. aquariorum A2-1000804 during ertapenem therapy improved with ciprofloxacin therapy.
DISCUSSION
The conserved sequence of the rpoB gene, encoding the bsubunit of the DNA-dependent RNA polymerase in the genus Aeromonas, has been used for delineating Aeromonas species (Küpfer et al., 2006; Lamy et al., 2010) . Therefore, in the present study, the Aeromonas species were identified by, in addition to traditional biochemical reactions, sequence analyses of the partial rpoB genes. We found that A. aquariorum was a predominant species causing bacteraemia. Such a fact highlights the potential clinical impact of A. aquariorium in, at least, southern Taiwan. A. aquariorum has been reported to be resistant to amoxicillin, cephalothin and cefoxitin , but the corresponding types of b-lactamases have not been studied. Therefore, information on the b-lactamase profile of this clinically important species is valuable for rational recommendations for antimicrobial therapy and justifies the clinical relevance of the present study.
By PCR and the colony hybridization technique, the distribution of cphA-related genes 93-95 % identical to A. hydrophila cphA genes (GenBank accession no. X57102) varied among Aeromonas species in the present study. cphA-related genes were noted in A. veronii and A. hydrophila, but not in A. caviae. Such results were concordant by Etest or agar dilution method.
CphA in bacteraemic Aeromonas isolates with those in previous studies (Balsalobre et al., 2009; Rossolini et al., 1995) . However, it is a novel finding that the cphA-related genes were present in all A. aquariorum isolates.
Determination of in vitro susceptibility to carbapenems by either the disc diffusion or dilution techniques among carbapenemase-producing Aeromonas isolates has often failed to yield a carbapenem-resistant phenotype (Massidda et al., 1991; Rossolini et al., 1996) . Likewise, our cphA + aeromonads rarely exhibited the imipenem-non-susceptible phenotype by the disc diffusion, Etest or agar dilution techniques with the recommended inoculum. However, with a higher inoculum, imipenem non-susceptibility was increasingly demonstrated among cphA + isolates, and absent among cphA 2 isolates. Among the detection methods for carbapenem resistance, the agar dilution test with large inocula was the most sensitive (97 %). The only exception, A. aquariorum A2-155, was susceptible to imipenem even when tested with a large inoculum. Rossolini et al. (1995) found that 20 % of cphA hybridized-positive A. hydrophila and A. veronii bv. sobria isolates were unable to express MBL activity, and they proposed that genetic modification had led to silencing of cphA in these species. Such a genetic modification was noted in A2-155, in which an extra inserted sequence in cphA might have altered the expression of CphA MBL. Owing to the failure of conventional in vitro susceptibility tests to detect carbapenemase production in aeromonads, we echo the advice of Rossolini et al. (1996) that it is prudent to consider Aeromonas species with carbapenemase-encoding genes as being resistant to carbapenems, unless they are verified to be unable to produce carbapenemase or to be carbapenem-susceptible by susceptibility testing using a large inoculum.
Similarly, the detection of cphA MBL activity, which could be inhibited by ion chelators, among aeromonads is inoculum-dependent. With the disc diffusion method and Etest, the zone diameters of inhibition increased and the MIC values decreased in the presence of EDTA among most cphA + isolates when tested with large inocula. Other phenotypic methods to detect MBL are the MHT (Lee et al., 2001) and synergy tests based on the ability of metal chelators (Arakawa et al., 2000) . However, even with large inocula, EDTA synergy disc tests and Etest detected MBL among only one-third and one-half, respectively, of cphA + aeromonads in our study. The MHT is recommended for the detection of carbapenemases in members of the Enterobacteriaceae by the CLSI (CLSI, 2009). However, the sensitivity and specificity of the test for detecting isolates with low-level carbapenemase production, such as aeromonads, are not known (CLSI, 2009 ). In our observation, the MHT performed well at detecting carbapenemase activity in our Aeromonas isolates.
The clinical relevance of CphA MBL in Aeromonas species remains obscure. In the literature, the clinical outcome in patients receiving carbapenems for infections caused by Table 2 . Presence of cphA-related genes (cphA), in vitro imipenem susceptibility studied with standard and high inocula, and the MHT in 51 blood isolates of different Total, 51 (100) 35 (69) 1 (2) 1 (2) 1 (2) 34 (67) 34 (67) *Detected by PCR. DImipenem-non-susceptible: an inhibition zone diameter ,16 mm by disc diffusion test or an MIC .4 mg
by Etest or agar dilution method.
dThe MHT result of an imipenem-susceptible isolate was indeterminate. §The MHT results of two isolates were indeterminate.
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